5 Best Biotech ETFs To Buy

1. Invesco S&P 500 Equal Weight Health Care ETF (NYSE:RSPH)

5-Year Performance as of August 4: 52.48%

Invesco S&P 500 Equal Weight Health Care ETF (NYSE:RSPH) tracks the S&P 500 Equal Weight Health Care Index, which evenly distributes the weight of stocks within the healthcare sector of the S&P 500 Index. This ETF was established in 2006 and as of August 2, 2023, it has a 30-day SEC yield of 0.69% and an expense ratio of 0.40%. Invesco S&P 500 Equal Weight Health Care ETF (NYSE:RSPH) is one of the best biotech ETFs to buy. 

Bio-Rad Laboratories, Inc. (NYSE:BIO) is a prominent holding of the Invesco S&P 500 Equal Weight Health Care ETF (NYSE:RSPH). The company produces and distributes life science research and clinical diagnostic products. On July 20, Bio-Rad Laboratories, Inc. (NYSE:BIO) authorized a new stock repurchase plan of $500 million. The company stated that the acquired shares will be utilized for supporting employee stock plans, financing acquisitions, and reducing dilution resulting from stock issuances.

According to Insider Monkey’s first quarter database, 47 hedge funds were bullish on Bio-Rad Laboratories, Inc. (NYSE:BIO), compared to 42 funds in the prior quarter. 

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily enewsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also check out Jim Rogers’ Latest Predictions and Investments and 10 Best Mutual Fund Managers of 2022.